ArticleJournal of diabetes and metabolic disorders2021

Pilot study in pharmacogenomic management of empagliflozin in type 2 diabetes mellitus patients.

Mahdieh Jamalizadeh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.